We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Lithium Americas' (LAC) Q1 Earnings Beat, Sales Miss Estimates
Read MoreHide Full Article
Lithium Americas Corp. (LAC - Free Report) incurred net loss of around $4.5 million or 5 cents per share compared with a net loss of roughly $4.6 million or 5 cents in the year-ago quarter. Loss per share was narrower than the Zacks Consensus Estimate of a loss of 6 cents.
Total sales rose 16.8% year over year to roughly $1.3 million. However, the figure trailed the Zacks Consensus Estimate of $1.8 million.
Lithium Americas Corp. Price, Consensus and EPS Surprise
Cauchari-Olaroz: The company inked a definitive transaction deal with Ganfeng Lithium Co., Ltd. in April 2019. Per the arrangement, Ganfeng has agreed to subscribe the newly issued 141 million shares of Minera Exar for roughly $160 million. The move enables Ganfeng to raise direct interest in the Cauchari-Olaroz project to 50% from 37.5%. Lithium Americas holds the remaining 50% interest.
Lithium Nevada: The company has submitted environmental baseline data and a conceptual Mine Plan of Operations to the Bureau of Land Management for the Thacker Pass project. The permitting process is underway. Lithium Americas is evaluating potential partnership and financing scenarios for the project.
Financials
As of Mar 31, 2019, cash and cash equivalents were $36.2 million, down 16.8% year over year. Lithium Americas has credit facility of $205 million to finance share of capital expenditures in Minera Exar. Since the credit facility started, the company has drawn $63.1 million.
Outlook
Lithium Americas stated that it focuses on advancing the Cauchari-Olaroz and Thacker Pass projects, which will enable it to address the growing global demand for lithium.
Pond construction for the Cauchari-Olaroz project is per schedule and is slated to complete all evaporation ponds covering during first-quarter 2020. Moreover, the construction of processing plant has started and is expected to be completed in the second half of 2020. The project is on track to reach production per the current development plan in second-half 2020.
Minera Exar is conducting a feasibility study to boost the stated production capacity of the project from 25,000 tons per annum (tpa) to a total of 40,000 tpa of lithium carbonate.
Lithium Americas is also advancing engineering work and mine plan design for the Thacker Pass project in Nevada.
Price Performance
Lithium Americas’ shares have plunged 42.7% in the past year compared with the 32.8% decline of the industry.
Zacks Rank & Key Picks
Lithium Americas currently carries a Zacks Rank #3 (Hold).
Materion has an expected earnings growth rate of 23.1% for 2019. The company’s shares have gained 18.2% in the past year.
Fortescue Metals has an expected earnings growth rate of 101.5% for the current year. The company’s shares have surged 58.9% in a year’s time.
AngloGold has an expected earnings growth rate of 86.8% for 2019. Its shares have rallied 38.1% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Lithium Americas' (LAC) Q1 Earnings Beat, Sales Miss Estimates
Lithium Americas Corp. (LAC - Free Report) incurred net loss of around $4.5 million or 5 cents per share compared with a net loss of roughly $4.6 million or 5 cents in the year-ago quarter. Loss per share was narrower than the Zacks Consensus Estimate of a loss of 6 cents.
Total sales rose 16.8% year over year to roughly $1.3 million. However, the figure trailed the Zacks Consensus Estimate of $1.8 million.
Lithium Americas Corp. Price, Consensus and EPS Surprise
Lithium Americas Corp. price-consensus-eps-surprise-chart | Lithium Americas Corp. Quote
Project Update
Cauchari-Olaroz: The company inked a definitive transaction deal with Ganfeng Lithium Co., Ltd. in April 2019. Per the arrangement, Ganfeng has agreed to subscribe the newly issued 141 million shares of Minera Exar for roughly $160 million. The move enables Ganfeng to raise direct interest in the Cauchari-Olaroz project to 50% from 37.5%. Lithium Americas holds the remaining 50% interest.
Lithium Nevada: The company has submitted environmental baseline data and a conceptual Mine Plan of Operations to the Bureau of Land Management for the Thacker Pass project. The permitting process is underway. Lithium Americas is evaluating potential partnership and financing scenarios for the project.
Financials
As of Mar 31, 2019, cash and cash equivalents were $36.2 million, down 16.8% year over year. Lithium Americas has credit facility of $205 million to finance share of capital expenditures in Minera Exar. Since the credit facility started, the company has drawn $63.1 million.
Outlook
Lithium Americas stated that it focuses on advancing the Cauchari-Olaroz and Thacker Pass projects, which will enable it to address the growing global demand for lithium.
Pond construction for the Cauchari-Olaroz project is per schedule and is slated to complete all evaporation ponds covering during first-quarter 2020. Moreover, the construction of processing plant has started and is expected to be completed in the second half of 2020. The project is on track to reach production per the current development plan in second-half 2020.
Minera Exar is conducting a feasibility study to boost the stated production capacity of the project from 25,000 tons per annum (tpa) to a total of 40,000 tpa of lithium carbonate.
Lithium Americas is also advancing engineering work and mine plan design for the Thacker Pass project in Nevada.
Price Performance
Lithium Americas’ shares have plunged 42.7% in the past year compared with the 32.8% decline of the industry.
Zacks Rank & Key Picks
Lithium Americas currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Materion Corporation (MTRN - Free Report) , Fortescue Metals Group Ltd. (FSUGY - Free Report) and AngloGold Ashanti Limited (AU - Free Report) , all currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Materion has an expected earnings growth rate of 23.1% for 2019. The company’s shares have gained 18.2% in the past year.
Fortescue Metals has an expected earnings growth rate of 101.5% for the current year. The company’s shares have surged 58.9% in a year’s time.
AngloGold has an expected earnings growth rate of 86.8% for 2019. Its shares have rallied 38.1% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>